Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2267 Large Cell Neuroendocrine Carcinoma of the Lung: Single-Centre Retrospective Cohort Study
Introduction: Large Cell Neuroendocrine Carcinoma (LCNEC) is a rare lung tumour, diagnosed based on high-grade features, presence of neuroendocrine morphology and immunohistochemical evidence of neuroendocrine markers. LCNEC was grouped with the pulmonary neuroendocrine carcinomas in 2015 WHO classification.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Martins Branco D, Cunha F, Claro I, Almodovar T,
Keywords: LCNEC,
Introduction: Insulinoma is a rare pancreatic neuroendocrine tumour. Metastatic insulinomas are a major therapeutic challenge.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Martins Branco D, Lucena Sampaio I, Brito M, Claro I,
Keywords: Insulinoma, PRRNT,
Introduction: VIPomas are rare neuroendocrine tumors (NETs) associated with vasoactive intestinal polypeptide (VIP) hypersecretion causing watery diarrhea, hypokalaemia and achlorhydria. They originate mostly in the pancreas and 60-80% are malignant. Hormonal co-secretion is rarely reported.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Marques B
Authors: Marques B, Martins R, Ribeiro J, Couto J, Ferrão H,
Keywords: vipoma, neuroendocrine, lanreotide, capecitabine, temozolamide,
#1735 Follow-Up in Neuroendocrine Neoplasms: Can Chromogranin A Be the Cofounder?
Introduction: Chromogranin A continues to be one of the most valuable markers for neuroendocrine tumors (NETs) however, it has several limitations.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Martins D, Batista C, Velez A, Macário F, Carrilho F,
Keywords: Neuroendocrine, follow-up, CgA, renal disease,
Introduction: Medullary thyroid carcinoma (MTC) is a well-differentiated neuroendocrine tumor and accounts for 5-10% of all thyroid cancers. Distant metastases frequently involve the liver and patient’s survival after diagnosis is around 20% at 10 years
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Marques B
Authors: Marques B, Martins R, Gonçalves B, Sousa M, Violante L,
Keywords: neuroendocrine, yttrium radioisotopes,